First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours

H. Gelderblom; J. A. Gietema; I. M. E. Desar; N. M. Ajmone; M. Jalving; J. R. Kroep; V. Nicolas; A. Vaslin; K. Tobal; D. Purcea; S. F. van Haren; L. Damstrup

doi:10.1016/j.annonc.2020.08.715

First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours

H. Gelderblom, J. A. Gietema, I. M. E. Desar, N. M. Ajmone, M. Jalving, J. R. Kroep, V. Nicolas, A. Vaslin, K. Tobal, D. Purcea, S. F. van Haren, L. Damstrup

Onderzoeksoutput: Meeting Abstract › Academic

Originele taal-2	English
Pagina's (van-tot)	S501-S502
Aantal pagina's	2
Tijdschrift	Annals of Oncology
Volume	31
DOI's	https://doi.org/10.1016/j.annonc.2020.08.715
Status	Published - sep.-2020
Evenement	ESMO Virtual Congress - Duur: 19-sep.-2020 → 18-okt.-2020

Toegang tot document

10.1016/j.annonc.2020.08.715

Handle.net

Permanente koppeling

Citeer dit

Gelderblom, H., Gietema, J. A., Desar, I. M. E., Ajmone, N. M., Jalving, M., Kroep, J. R., Nicolas, V., Vaslin, A., Tobal, K., Purcea, D., van Haren, S. F., & Damstrup, L. (2020). First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours. Annals of Oncology, 31, S501-S502. https://doi.org/10.1016/j.annonc.2020.08.715

@article{1b92c1666f8c49d7b4d15548c239e24e,

title = "First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours",

author = "H. Gelderblom and Gietema, {J. A.} and Desar, {I. M. E.} and Ajmone, {N. M.} and M. Jalving and Kroep, {J. R.} and V. Nicolas and A. Vaslin and K. Tobal and D. Purcea and {van Haren}, {S. F.} and L. Damstrup",

year = "2020",

month = sep,

doi = "10.1016/j.annonc.2020.08.715",

language = "English",

volume = "31",

pages = "S501--S502",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

note = "ESMO Virtual Congress ; Conference date: 19-09-2020 Through 18-10-2020",

}

Gelderblom, H, Gietema, JA, Desar, IME, Ajmone, NM, Jalving, M, Kroep, JR, Nicolas, V, Vaslin, A, Tobal, K, Purcea, D, van Haren, SF & Damstrup, L 2020, 'First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours', Annals of Oncology, vol. 31, blz. S501-S502. https://doi.org/10.1016/j.annonc.2020.08.715

TY - JOUR

T1 - First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours

AU - Gelderblom, H.

AU - Gietema, J. A.

AU - Desar, I. M. E.

AU - Ajmone, N. M.

AU - Jalving, M.

AU - Kroep, J. R.

AU - Nicolas, V.

AU - Vaslin, A.

AU - Tobal, K.

AU - Purcea, D.

AU - van Haren, S. F.

AU - Damstrup, L.

PY - 2020/9

Y1 - 2020/9

U2 - 10.1016/j.annonc.2020.08.715

DO - 10.1016/j.annonc.2020.08.715

M3 - Meeting Abstract

SN - 0923-7534

VL - 31

SP - S501-S502

JO - Annals of Oncology

JF - Annals of Oncology

T2 - ESMO Virtual Congress

Y2 - 19 September 2020 through 18 October 2020

ER -